MiR-181b plays a role also in immune response regulation: recently, Di Marco and colleagues demonstrated that miR-181b modulates T cells’ cytotoxic activity against CLL cells: firstly, the author found that the expression of miR-181b increases in CLL cells by CD40-CD40L interaction. This evidence concerns the gene CD40 and B-cell chronic lymphocytic leukemia.